Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Normarin Baby is a sterile, isotonic nasal spray developed by AICORE Bulgaria, specifically formulated for infants from birth and young children. The product consists of a filtered seawater solution diluted with purified water to a physiological concentration of 0.9% NaCl. It is designed for daily nasal hygiene, moisturizing the nasal mucosa, and relieving nasal congestion associated with conditions such as the common cold, sinusitis, and allergies. By thinning and washing away excess mucus, crusts, and environmental irritants like dust and pollen, it helps maintain the protective function of the respiratory mucosa and facilitates easier breathing. The spray utilizes bag-on-valve technology, which ensures the sterility of the solution throughout its use and allows for effective application from any angle, which is particularly beneficial for use in infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Normarin Baby.